Are glucagon-like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV?

HIV Med. 2024 Mar;25(3):404-406. doi: 10.1111/hiv.13587. Epub 2023 Nov 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Body Mass Index
  • Body Weight
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptide 1 / agonists
  • HIV Infections* / drug therapy
  • Humans
  • Hypoglycemic Agents

Substances

  • Glucagon-Like Peptide 1
  • Hypoglycemic Agents